This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Nov;138(5 Pt 1):801-3.

doi: 10.1016/s0002-8703(99)70001-3.

Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance

B A Bart

PMID: 10539807
DOI: 10.1016/s0002-8703(99)70001-3

Review

Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance

B A Bart. Am Heart J. 1999 Nov.

. 1999 Nov;138(5 Pt 1):801-3.

doi: 10.1016/s0002-8703(99)70001-3.

Author

B A Bart

PMID: 10539807
DOI: 10.1016/s0002-8703(99)70001-3

No abstract available

PubMed Disclaimer

Comment on

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Knight EL, et al. Am Heart J. 1999 Nov;138(5 Pt 1):849-55. doi: 10.1016/s0002-8703(99)70009-8. Am Heart J. 1999. PMID: 10539815 Clinical Trial.

Similar articles

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Knight EL, et al. Am Heart J. 1999 Nov;138(5 Pt 1):849-55. doi: 10.1016/s0002-8703(99)70009-8. Am Heart J. 1999. PMID: 10539815 Clinical Trial.
Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators.
Kostis JB, Shelton B, Gosselin G, Goulet C, Hood WB Jr, Kohn RM, Kubo SH, Schron E, Weiss MB, Willis PW 3rd, Young JB, Probstfield J. Kostis JB, et al. Am Heart J. 1996 Feb;131(2):350-5. doi: 10.1016/s0002-8703(96)90365-8. Am Heart J. 1996. PMID: 8579032 Clinical Trial.
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.
Testani JM, Kimmel SE, Dries DL, Coca SG. Testani JM, et al. Circ Heart Fail. 2011 Nov;4(6):685-91. doi: 10.1161/CIRCHEARTFAILURE.111.963256. Epub 2011 Sep 8. Circ Heart Fail. 2011. PMID: 21903907 Free PMC article. Clinical Trial.
Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
Weinberg MS. Weinberg MS. Clin Ther. 1993 Jan-Feb;15(1):3-17; discussion 2. Clin Ther. 1993. PMID: 8458051 Review.
Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
Frank GJ. Frank GJ. J Hypertens Suppl. 1989 Sep;7(5):S17-22. J Hypertens Suppl. 1989. PMID: 2553900 Review.

See all similar articles

Cited by

Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.
Iyngkaran P, Thomas M, Majoni W, Anavekar NS, Ronco C. Iyngkaran P, et al. Cardiorenal Med. 2012 Dec;2(4):281-297. doi: 10.1159/000342487. Epub 2012 Oct 31. Cardiorenal Med. 2012. PMID: 23381594 Free PMC article.
Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome.
Preeti J, Alexandre M, Pupalan I, Merlin TC, Claudio R. Preeti J, et al. Curr Cardiol Rev. 2016;12(3):186-94. doi: 10.2174/1573403x12666160606120958. Curr Cardiol Rev. 2016. PMID: 27280302 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information